Literature DB >> 34850664

ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.

Binliang Wang1,2, Yuanyuan Cai3, Xiaobo Li2, Yiming Kong2, Haiwei Fu2, Jianying Zhou1.   

Abstract

Lung adenocarcinoma (LUAD) is originated from the mucus-producing glands of the lungs. The involvement of long noncoding RNAs (lncRNAs) has been discovered in multiple diseases. In the present research, we aimed to unmask the role of C2CD4D and THEM5 antisense RNA 1 (C2CD4D-AS1) in LUAD. RT-qPCR or western blot analysis was respectively applied in the detection of RNA or protein expressions. The function of C2CD4D-AS1 in LUAD was assessed by functional assays. Through ChIP, RNA pull down, DNA pull down, RIP and luciferase reporter assays, the in-depth regulatory mechanism of C2CD4D-AS1 in LUAD was explored. C2CD4D-AS1 was dramatically overexpressed in LUAD tissues and cell lines. As a result, depletion of C2CD4D-AS1 significantly repressed cell proliferation, migration, invasion and stimulated cell apoptosis in LUAD. Mechanistically, ETS variant transcription factor 4 (ETV4) activated the transcription of C2CD4D-AS1 and stimulated its up-regulation in LUAD cells, thus affecting LUAD cell biological functions. Furthermore, C2CD4D-AS1 sponged microRNA-3681-3p (miR-3681-3p) and regulated NIMA-related kinase 2 (NEK2), thus participating in modulating LUAD cell biological behaviors. To conclude, C2CD4D-AS1 up-regulation induced by ETV4 enhanced NEK2 expression by sequestering miR-3681-3p to contribute to the malignant behaviors of LUAD cells.

Entities:  

Keywords:  C2CD4D-AS1; ETV4; Lung adenocarcinoma; NEK2; miR-3681-3p

Mesh:

Substances:

Year:  2021        PMID: 34850664      PMCID: PMC8726644          DOI: 10.1080/15384101.2021.2005273

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  27 in total

Review 1.  ceRNA in cancer: possible functions and clinical implications.

Authors:  Xiaolong Qi; Da-Hong Zhang; Nan Wu; Jun-Hua Xiao; Xiang Wang; Wang Ma
Journal:  J Med Genet       Date:  2015-09-10       Impact factor: 6.318

Review 2.  Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression.

Authors:  Mohamed Amine Bouhlel; Melanie Lambert; Marie-Helene David-Cordonnier
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Screening key lncRNAs for human lung adenocarcinoma based on machine learning and weighted gene co-expression network analysis.

Authors:  Yu Wang; Junfeng Fu; Ze Wang; Zhenyang Lv; Zhe Fan; Ting Lei
Journal:  Cancer Biomark       Date:  2019       Impact factor: 4.388

4.  High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.

Authors:  Chuanhui Chen; Shanshan Peng; Penghui Li; Lin Ma; Xin Gan
Journal:  Mol Cell Biochem       Date:  2020-08-06       Impact factor: 3.396

5.  Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression.

Authors:  Hao Jiang; Tingting Li; Yi Qu; Xiang Wang; Bing Li; Jiagui Song; Xiaoran Sun; Yan Tang; Junhu Wan; Yu Yu; Jun Zhan; Hongquan Zhang
Journal:  Cancer Lett       Date:  2018-03-29       Impact factor: 8.679

Review 6.  Adenocarcinoma classification: patterns and prognosis.

Authors:  E Kuhn; P Morbini; A Cancellieri; S Damiani; A Cavazza; C E Comin
Journal:  Pathologica       Date:  2018-03

7.  ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.

Authors:  Adriana C Rodriguez; Jeffery M Vahrenkamp; Kristofer C Berrett; Kathleen A Clark; Katrin P Guillen; Sandra D Scherer; Chieh-Hsiang Yang; Bryan E Welm; Margit M Janát-Amsbury; Barbara J Graves; Jason Gertz
Journal:  Cancer Res       Date:  2020-02-11       Impact factor: 12.701

8.  STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4.

Authors:  Hui Wang; Xisong Huo; Xin-Rong Yang; Jia He; Lijun Cheng; Na Wang; Xuan Deng; Haojie Jin; Ning Wang; Cun Wang; Fangyu Zhao; Jingyuan Fang; Ming Yao; Jia Fan; Wenxin Qin
Journal:  Mol Cancer       Date:  2017-08-14       Impact factor: 27.401

9.  The long noncoding RNA LINC00312 induces lung adenocarcinoma migration and vasculogenic mimicry through directly binding YBX1.

Authors:  Zhenzi Peng; Jun Wang; Bin Shan; Bin Li; Wei Peng; Yeping Dong; Wenwen Shi; Wenyuan Zhao; Dan He; Minghao Duan; Yuanda Cheng; Chunfang Zhang; Chaojun Duan
Journal:  Mol Cancer       Date:  2018-11-23       Impact factor: 27.401

Review 10.  Targeting Transcription Factors for Cancer Treatment.

Authors:  Mélanie Lambert; Samy Jambon; Sabine Depauw; Marie-Hélène David-Cordonnier
Journal:  Molecules       Date:  2018-06-19       Impact factor: 4.411

View more
  2 in total

1.  SYNPRED: prediction of drug combination effects in cancer using different synergy metrics and ensemble learning.

Authors:  António J Preto; Pedro Matos-Filipe; Joana Mourão; Irina S Moreira
Journal:  Gigascience       Date:  2022-09-26       Impact factor: 7.658

2.  MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling.

Authors:  Dongxiao Ding; Yunqiang Zhang; Xuede Zhang; Ke Shi; Wenjun Shang; Junjie Ying; Li Wang; Zhongjie Chen; Haihua Hong
Journal:  Mol Biotechnol       Date:  2022-04-19       Impact factor: 2.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.